You are here

vadadustat

FDA approves Akebia's anemia drug

Reuters

Wed, 03/27/24 - 10:32 pm

chronic kidney disease

Akebia's Appeal for Anemia in CKD Drug Delayed Again

BioSpace

Tue, 02/21/23 - 04:40 pm

Akebia Therapeutics

chronic kidney disease

Akebia Stands by Anemia in CKD Drug in Dispute Resolution Request

BioSpace

Mon, 11/7/22 - 10:48 am

Akebia Therapeutica

chronic kidney disease

Is the HIF-PHI class of next-generation kidney drugs doomed in the U.S.?

MedCity News

Mon, 07/25/22 - 10:33 am

Akebia Regains Rights to Anemia Drug After Otsuka Partnership Dissolves

BioSpace

Mon, 07/4/22 - 11:56 pm

In a one-two gut punch after kidney drug CRL, Akebia slapped with partial hold and will lay off 42% of staff

Endpoints

Thu, 04/7/22 - 10:49 am

Akebia Therapeutics

FDA rejects Akebia drug, dealing another blow to anemia pills

BioPharma Dive

Thu, 03/31/22 - 10:24 am

Akebia Therapeutics

chronic kidney disease

Akebia scrapes together $85M war chest to commercialize vada as PDUFA date looms

Endpoints

Thu, 02/24/22 - 09:30 am

Akebia confirms its place in the anemia race

EP Vantage

Tue, 05/5/20 - 12:57 pm

clinical trials

The crucial data readouts coming soon for small biotechs

EP Vantage

Thu, 04/23/20 - 12:37 pm

clinical trials

Blueprint Medicines

TG Therapeutics

$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease

CP Wire

Thu, 06/28/18 - 09:30 am

Akebia Therapeutics

Here’s the deal with Akebia’s anemia drug that caused a 50% stock hike today

Bizjournals.com

Wed, 09/9/15 - 10:02 pm

Akebia Therapeutics